NGM Clinical Study Site 127 — San Francisco, California

NGM Clinical Study Site 127 is a clinical research site located in San Francisco, California, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

NGM Clinical Study Site 127 has participated in 1 clinical trials.

Therapeutic areas: Primary Sclerosing Cholangitis.

Sponsors: NGM Biopharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Francisco

Browse all research sites in California · View every site in San Francisco

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NGM Clinical Study Site 127?

NGM Clinical Study Site 127 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NGM Clinical Study Site 127 conducted?

NGM Clinical Study Site 127 has 1 clinical trials on record. Their work covers Primary Sclerosing Cholangitis.

Is NGM Clinical Study Site 127 accredited by Crixeo Clinical Trials?

NGM Clinical Study Site 127 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NGM Clinical Study Site 127?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.